Purpose
to develop new drug candidates for human African trypanosomiasis and visceral leishmaniasis through the pre-clinical stage and ready for an Investigational New Drug filing, and the completion of phase I clinical studies
Grantee
Division
Global Development,
Global Health
Date
OCTOBER 2007
Region served
AFRICA
Committed amount
$27,229,285
Grant topic
Global Health and Development Public Awareness and Analysis,
Neglected Tropical Diseases
Duration (months)
60
Grantee location
Geneva, Switzerland
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.